Reed Joanne H, Gorny Miroslaw K, Li Liuzhe, Cardozo Timothy, Buyon Jill P, Clancy Robert M
Dept. Immunology, Garvan Institute of Medical Research, Sydney, Australia.
Dept. Pathology, New York University School of Medicine, New York, USA.
J Autoimmun. 2017 May;79:99-104. doi: 10.1016/j.jaut.2017.01.004. Epub 2017 Jan 22.
The detection of cardiac conduction defects in an 18-24 week old foetus in the absence of structural abnormalities predicts with near certainty the presence of autoantibodies against 60kD and 52kD SSA/Ro in the mother regardless of her health status. Previous studies have emphasized these autoantibodies as key mediators of tissue injury. The aim of this study was to focus on the anti-Ro52 response to determine whether these autoantibodies originate from progenitors that are inherently self-reactive or from B-cells that acquire self-reactivity during an immune response. We traced the evolution of two anti-Ro52 autoantibodies isolated from circulating IgG1-switched B-cells from an asymptomatic mother of a child with third degree congenital heart block. The autoantibodies were expressed as their immune form and as pre-immune ancestors by reverting somatic mutations to germline sequence. The reactivity of pre-immune and immune antibodies for Ro52, Ro60, La and DNA was measured. Both anti-Ro52 autoantibodies exhibited a low frequency of somatic mutations (3-4%) and utilised the same heavy and light chain genes but represented distinct clones based on differing complementarity determining region sequences. Pre- and post-immune antibodies showed specific binding to Ro52 with no measurable reactivity for other autoantigens. Ro52 binding was higher for immune antibodies compared to pre-immune counterparts demonstrating that autoreactivity was enhanced by affinity maturation. These data indicate that Ro52 reactivity is an intrinsic property of the germline antibody repertoire in a mother with a pathogenic antibody defined by cardiac injury in her offspring, and implies defects in both central and peripheral tolerance mechanisms.
在18 - 24周龄胎儿中检测到心脏传导缺陷且无结构异常,几乎可以肯定地预测母亲体内存在针对60kD和52kD SSA/Ro的自身抗体,无论其健康状况如何。先前的研究强调这些自身抗体是组织损伤的关键介质。本研究的目的是聚焦于抗Ro52反应,以确定这些自身抗体是源自固有自身反应性的祖细胞,还是源自免疫反应期间获得自身反应性的B细胞。我们追踪了从一名患有三度先天性心脏传导阻滞患儿的无症状母亲的循环IgG1转换B细胞中分离出的两种抗Ro52自身抗体的演变。通过将体细胞突变恢复为种系序列,将自身抗体表达为其免疫形式和免疫前祖细胞形式。测量了免疫前和免疫抗体对Ro52、Ro60、La和DNA的反应性。两种抗Ro52自身抗体的体细胞突变频率均较低(3 - 4%),并利用相同的重链和轻链基因,但基于不同的互补决定区序列代表不同的克隆。免疫前和免疫后抗体均显示与Ro52特异性结合,对其他自身抗原无可测量的反应性。与免疫前对应物相比,免疫抗体对Ro52的结合更高,表明亲和力成熟增强了自身反应性。这些数据表明,Ro52反应性是具有致病性抗体(由其后代的心脏损伤定义)的母亲种系抗体库的固有特性,并暗示中枢和外周耐受机制均存在缺陷。